 JERSEY CITY, N.J., Oct. 13, 2021 GLOBE NEWSWIRE -- SCYNEXIS, Inc. NASDAQ: SCYX, a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced presentations of a pooled data analysis from its successful VANISH clinical development program during two October medical meetings: the Nurse Practitioners in Womens Health NPWH 24th Annual Premier Womens Healthcare Conference and the 4th Congress of the International Society for Infectious Diseases in Obstetrics and Gynecology ISIDOG. 